The potential role of gut microbiota in pancreatic disease: A systematic review

Pancreatology

Volumn 17, Issue 6, 2017, Pages 867-874

  Memba, Robert ^a   Duggan, Sinead N ^a   Ni Chonchubhair, Hazel M ^a   Griffin, Oonagh M ^a   Bashir, Yasir ^a   O'Connor, Donal B ^a   Murphy, Anne ^a   McMahon, Jean ^a   Volcov, Yuri ^b   Ryan, Barbara M ^a   Conlon, Kevin C ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

^b ST JAMES S HOSPITAL   (Ireland)

Author keywords

Chronic pancreatitis; Microbiome; Microbiota; Pancreatic diseases; Pancreatic ductal cancer

Indexed keywords

BACTERIAL DNA;

ACUTE PANCREATITIS; BACTEROIDETES; BIFIDOBACTERIUM; CHRONIC PANCREATITIS; COCHRANE LIBRARY; EMBASE; ENTEROBACTER; ENTEROBACTERIACEAE; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; GRANULICATELLA ADIACENS; HUMAN; INTESTINE FLORA; KLEBSIELLA; LACTOBACILLUS; MEDLINE; MORGANELLA; NEISSERIA; NEISSERIA ELONGATE; NONHUMAN; PANCREAS CANCER; PANCREAS DISEASE; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS MITIS; MICROBIOLOGY; PHYSIOLOGY;

GASTROINTESTINAL MICROBIOME; HUMANS; PANCREATIC DISEASES;

EID: 85029488393     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1016/j.pan.2017.09.002     Document Type: Review

References (58)

1. Leal-Lopes, C., Velloso, F.J., Campopiano, J.C., Sogayar, M.C., Correa, R.G., Roles of commensal microbiota in pancreas homeostasis and pancreatic pathologies. J diabetes Res, 2015, 2015.
2. Ramakrishna, B.S., Role of the gut microbiota in human nutrition and metabolism. J gastroenterology hepatology 28:S4 (2013), 9–17.
3. Verdu, E.F., Galipeau, H.J., Jabri, B., Novel players in coeliac disease pathogenesis: role of the gut microbiota. Nat Rev Gastroenterol Hepatol 12:9 (2015), 497–506.
4. Distrutti, E., Monaldi, L., Ricci, P., Fiorucci, S., Gut microbiota role in irritable bowel syndrome: new therapeutic strategies. World J Gastroenterol 22:7 (2016), 2219–2241.
5. Sheehan, D., Moran, C., Shanahan, F., The microbiota in inflammatory bowel disease. J gastroenterology 50:5 (2015), 495–507.
6. Sarner, M., Cotton, P.B., Classification of pancreatitis. Gut 25:7 (1984), 756–759.
7. Yadav, D., Hawes, R.H., Brand, R.E., Anderson, M.A., Money, M.E., Banks, P.A., et al. Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis. Archives Intern Med 169:11 (2009), 1035–1045.
8. Vonlaufen, A., Spahr, L., Apte, M.V., Frossard, J.-L., Alcoholic pancreatitis: a tale of spirits and bacteria. World J Gastrointest Pathophysiol 5:2 (2014), 82–90.
9. Capurso, G., Signoretti, M., Archibugi, L., Stigliano, S., Delle Fave, G., Systematic review and meta-analysis: small intestinal bacterial overgrowth in chronic pancreatitis. United Eur Gastroenterology J, 2016 2050640616630117.
10. Kim, D.B., Paik, C.-N., Sung, H.J., Chung, W.C., Lee, K.-M., Yang, J.-M., et al. Breath hydrogen and methane are associated with intestinal symptoms in patients with chronic pancreatitis. Pancreatology 15:5 (2015), 514–518.
11. Power, S.E., O'Toole, P.W., Stanton, C., Ross, R.P., Fitzgerald, G.F., Intestinal microbiota, diet and health. Br J Nutr 111:03 (2014), 387–402.
12. Yeo, T.P., Hruban, R.H., Brody, J., Brune, K., Fitzgerald, S., Yeo, C.J., Assessment of “gene–environment” interaction in cases of familial and sporadic pancreatic cancer. J Gastrointest Surg 13:8 (2009), 1487–1494.
13. Farrell, J.J., Zhang, L., Zhou, H., Chia, D., Elashoff, D., Akin, D., et al. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut 61:4 (2012 Apr), 582–588.
14. Milani, C., Ferrario, C., Turroni, F., Duranti, S., Mangifesta, M., van Sinderen, D., et al. The human gut microbiota and its interactive connections to diet. J Hum Nutr Diet 29:5 (2016), 539–546.
15. Kelly, C.R., Khoruts, A., Staley, C., Sadowsky, M.J., Abd, M., Alani, M., et al. Effect of fecal microbiota transplantation on recurrence in multiply recurrent Clostridium difficile infection: a randomized trial. Ann Intern Med 165:9 (2016), 609–616.
16. Claesson, M.J., Cusack, S., O'Sullivan, O., Greene-Diniz, R., de Weerd, H., Flannery, E., et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U. S. A 108:Suppl 1 (2011), 4586–4591.
17. Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev, 4, 2015, 1.
18. Stang, A., Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:9 (2010), 603–605.
19. Wells, G.A.S.B., O'Connell, D., Peterson, J., Welch, V., Losos, M., Tugwell, P., The Newcastle-Ottawa Scale (NOS) for Assessing the Quality if Nonrandomized Studies in Meta-Analyses. 2009 Available from: URL http://wwwohrica/programs/clinical_epidemiology/oxfordhtm [cited 2009 Oct 19].
20. Tan, C., Ling, Z., Huang, Y., Cao, Y., Liu, Q., Cai, T., et al. Dysbiosis of intestinal microbiota associated with inflammation involved in the progression of acute pancreatitis. Pancreas 44:6 (2015), 868–875.
21. Jandhyala, S.M., Madhulika, A., Deepika, G., Rao, G.V., Reddy, D.N., Subramanyam, C., et al. Altered intestinal microbiota in patients with chronic pancreatitis: implications in diabetes and metabolic abnormalities. Sci Rep, 7, 2017, 43640.
22. Gorovits, E., Tokareva, E., Khlynova, O., Zhelobov, V., El'kin, V., Complex evaluation of intestine microbiocenosis condition in patients with chronic pancreatitis. Zhurnal Mikrobiol Epidemiol i Immunobiol 4 (2012), 73–76.
23. Wüst, J., Smid, I., Salfinger, M., (eds.) Experience of gas-liquid chromatography in clinical microbiology, 1989 Annales de biologie clinique.
24. Zhang, L., Farrell, J.J., Zhou, H., Elashoff, D., Akin, D., Park, N.H., et al. Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer. Gastroenterology 138:3 (2010), 949–957 e7.
25. Savitskaya, K., Melnikova, Y., Vorobyev, A., Zagalskaya, N., Evaluation of the colonic content microenvironment in patients with chronic pancreatitis. Vestnik-Rossiiskaia Akad Meditsinskikh Nauk 4 (2002), 20–23.
26. Michaud, D.S., Izard, J., Wilhelm-Benartzi, C.S., You, D.-H., Grote, V.A., Tjønneland, A., et al. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. Gut 62:12 (2013 Dec), 1764–1770.
27. Fan, X., Alekseyenko, A.V., Wu, J., Peters, B.A., Jacobs, E.J., Gapstur, S.M., et al. Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study. Gut, 2016 Oct 14 pii: gutjnl-2016-312580.
28. Torres, P.J., Fletcher, E.M., Gibbons, S.M., Bouvet, M., Doran, K.S., Kelley, S.T., Characterization of the salivary microbiome in patients with pancreatic cancer. Peer J, 3, 2015, e1373.
29. Half, E., Keren, N., Dorfman, T., Reshef, L., Lachter, I., Kluger, Y., et al. Specific changes in fecal microbiota may differentiate pancreatic cancer patients from healthy individuals. Ann Oncol, 26, 2015, iv48.
30. Lin, I.H., Wu, J., Cohen, S.M., Chen, C., Bryk, D., Marr, M., et al. Pilot study of oral microbiome and risk of pancreatic cancer. Cancer Res, 73(8), 2013.
31. Kumar, K., Ghoshal, U.C., Srivastava, D., Misra, A., Mohindra, S., Small intestinal bacterial overgrowth is common both among patients with alcoholic and idiopathic chronic pancreatitis. Pancreatology 14:4 (2014), 280–283.
32. Layer, P., von der Ohe, M.R., Holst, J.J., Jansen, J.B., Grandt, D., Holtmann, G., et al. Altered postprandial motility in chronic pancreatitis: role of malabsorption. Gastroenterology 112:5 (1997), 1624–1634.
33. Balzan, S., de Almeida Quadros, C., de Cleva, R., Zilberstein, B., Cecconello, I., Bacterial translocation: overview of mechanisms and clinical impact. J Gastroenterol Hepatol 22:4 (2007), 464–471.
34. Dukowicz, A.C., Lacy, B.E., Levine, G.M., Small intestinal bacterial overgrowth: a comprehensive review. Gastroenterol Hepatol (N Y) 3:2 (2007), 112–122.
35. Hu, Y., Teng, C., Yu, S., Wang, X., Liang, J., Bai, X., et al. Inonotus obliquus polysaccharide regulates gut microbiota of chronic pancreatitis in mice. Amb Express, 7(1), 2017, 39.
36. Saez-Lara, M.J., Gomez-Llorente, C., Plaza-Diaz, J., Gil, A., The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials. BioMed Res Int, 2015, 2015.
37. Tojo, R., Suárez, A., Clemente, M.G., de los Reyes-Gavilán, C.G., Margolles, A., Gueimonde, M., et al. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis. World J Gastroenterol 20:41 (2014), 15163–15176.
38. Li, L., Somerset, S., The clinical significance of the gut microbiota in cystic fibrosis and the potential for dietary therapies. Clin Nutr 33:4 (2014), 571–580.
39. Gou, S., Yang, Z., Liu, T., Wu, H., Wang, C., Use of probiotics in the treatment of severe acute pancreatitis: a systematic review and meta-analysis of randomized controlled trials. Crit Care, 18(2), 2014, 1.
40. AlFaleh, K., Anabrees, J., Bassler, D., Al-Kharfi, T., Cochrane Review: probiotics for prevention of necrotizing enterocolitis in preterm infants. Evidence-Based Child Health A Cochrane Rev J 7:6 (2012), 1807–1854.
41. Picard, C., Fioramonti, J., Francois, A., Robinson, T., Neant, F., Matuchansky, C., Review article: bifidobacteria as probiotic agents–physiological effects and clinical benefits. Alimentary Pharmacol Ther 22:6 (2005), 495–512.
42. Ríos-Covián, D., Ruas-Madiedo, P., Margolles, A., Gueimonde, M., de los Reyes-Gavilán, C.G., Salazar, N., Intestinal short chain fatty acids and their link with diet and human health. Front Microbiol, 2016, 7.
43. O'Callaghan, A., van Sinderen, D., Bifidobacteria and their role as members of the human gut microbiota. Front Microbiol, 7, 2016, 925.
44. Ventura, M., VS, D., Fitzgerald, G.F., Zink, T., Insights into the taxonomy, genetics and physiology of bifidobacteria. Ant Van Leeuwenhoek 86:3 (2004), 205–223.
45. Morgan, X.C., Tickle, T.L., Sokol, H., Gevers, D., Devaney, K.L., Ward, D.V., et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol, 13(9), 2012, 1.
46. Yanagisawa, N., Haruta, I., Shimizu, K., Furukawa, T., Higuchi, T., Shibata, N., et al. Identification of commensal flora-associated antigen as a pathogenetic factor of autoimmune pancreatitis. Pancreatology 14:2 (2014), 100–106.
47. Ren, G.Y., M, Li, K., Hu, Y., Wang, Y., Xu, X., Qu, J., Seleno-lentinan prevents chronic pancreatitis development and modulates gut microbiota in mice. J Funct Foods 22 (2016), 177–188.
48. Chang, J.S., Tsai, C.-R., Chen, L.-T., Shan, Y.-S., Investigating the association between periodontal disease and risk of pancreatic cancer. Pancreas 45:1 (2016), 134–141.
49. Michaud, D.S., Izard, J., Microbiota, oral microbiome, and pancreatic cancer. Cancer J (Sudbury, Mass), 20(3), 2014, 203.
50. Wang, Y., Zhang, F.C., Wang, Y.J., Helicobacter pylori and pancreatic cancer risk: a meta- analysis based on 2,049 cases and 2,861 controls. Asian Pac J Cancer Prev 15:11 (2014), 4449–4454.
51. Xiao, M., W, Y., Gao, Y., Association between Helicobacters pylori Infection and Pancreatic cancer development: a meta-analysis. PLos One 8:9 (2013), 1–11.
52. Trikudanathan, G., Philip, A., Dasanu, C.A., Baker, W.L., Association between Helicobacter pylori infection and pancreatic cancer. A cumulative meta-analysis. JOP 12:1 (2011), 26–31.
53. Guo, Y., Liu, W., Wu, J., Helicobacter pylori infection and pancreatic cancer risk: a meta-analysis. J Cancer Res Ther 12:Supplement (2016), C229–C232.
54. Schulte, A., Pandeya, N., Fawcett, J., Fritschi, L., Risch, H.A., Webb, P.M., et al. Association between Helicobacter pylori and pancreatic cancer risk: a meta-analysis. Cancer Causes Control 26:7 (2015), 1027–1035.
55. Risch, H.A., Lu, L., Kidd, M.S., Wang, J., Zhang, W., Ni, Q., et al. Helicobacter pylori seropositivities and risk of pancreatic carcinoma. Cancer Epidemiol Biomarkers Prev 23:1 (2014), 172–178.
56. Graf, D., Di Cagno, R., Fak, F., Flint, H.J., Nyman, M., Saarela, M., et al. Contribution of diet to the composition of the human gut microbiota. Microb Ecol Health Dis, 26, 2015, 26164.
57. Simpson, H.L., Campbell, B.J., Review article: dietary fibre-microbiota interactions. Aliment Pharmacol Ther 42:2 (2015), 158–179.
58. Fisher, W.E., Altered microbiome in pancreatitis, diabetes and pancreatic cancer. National Institute of health (NIH) research project-cooperative agreements baylor collefe of medicine. 2016, United States(Research project), Houston, TX.